BGU researchers are on the verge of a breakthrough that is bringing the world closer to a cure for diabetes.
Researchers at BGU’s Clinical Islet Laboratory are pursuing three major goals: transplants and new drugs, gene therapy, and the creation of a “transgenic” mouse that can tolerate human material for experimentation. They’re working on new drugs based on the alpha-1-antitrypsin (AAT) protein that reduces inflammation. Recent clinical trials demonstrated that infusion of AAT in recently diagnosed type 1 diabetes patients could eventually eliminate the need for insulin injections. A new clinical trial is under way to evaluate AAT dosing levels and duration.
Diabetes Videossee all videos
Diabetes Newssee all news
“Super Enzyme” Improves Glucose Level Testing
BGU researchers engineer a new method that measures blood-sugar levels faster and more accurately.
Reversing Type 1 Diabetes
Using the alpha-1 protein, Prof. Eli Lewis has eliminated some patients’ need for insulin injections.
Wine Has Demonstrable Benefits for Type 2 Diabetes
A two-year BGU study shows moderate wine consumption can raise good cholesterol while lowering the bad.